Roschier represents Mobidiag in the sale of the company to Hologic

The shareholders of Mobidiag, a Finnish-French biotechnology company, have agreed to sell the company to US-based medical technology company Hologic, Inc. for an enterprise value of approximately EUR 668 million. Roschier advises Mobidiag and its share...

Read more